EUVIMEDEUVIMED entdecken
LeitlinieOpen Access

Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023

Katherine E Fleming-Dutra, Jefferson M Jones, Lauren E Roper, Mila M Prill, Ismael R Ortega-Sanchez, Danielle L Moulia, Megan Wallace, Monica Godfrey, Karen R Broder, Naomi K Tepper, Oliver Brooks, Pablo J Sánchez und 4 weitere

MMWR. Morbidity and Mortality Weekly Report · 13.10.2023 · 72 (41) · 1115-1122

DOI: 10.15585/mmwr.mm7241e1 ↗

Kurz gefasst

Leitlinie in der Zeitschrift MMWR. Morbidity and Mortality Weekly Report, online erschienen am 13.10.2023. Verfasst von Katherine E Fleming-Dutra und 15 weiteren Autor:innen. Hauptthemen laut MEDLINE: Communicable Diseases, Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus Vaccines, Respiratory Syncytial Virus, Human. Die Arbeit wurde bisher 310-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Communicable DiseasesRespiratory Syncytial Virus InfectionsRespiratory Syncytial Virus VaccinesRespiratory Syncytial Virus, HumanRespiratory Tract InfectionsFemaleHumansInfantPregnancyAdvisory CommitteesUnited StatesVaccination

Substanzen

Respiratory Syncytial Virus Vaccines

Zitieren

APA

Fleming-Dutra, K. E., Jones, J. M., Roper, L. E., Prill, M. M., Ortega-Sanchez, I. R., Moulia, D. L., Wallace, M., Godfrey, M., Broder, K. R., Tepper, N. K., Brooks, O., Sánchez, P. J., Kotton, C. N., Mahon, B. E., Long, S. S., & McMorrow, M. L. (2023). Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023. MMWR. Morbidity and Mortality Weekly Report, 72(41), 1115-1122. https://doi.org/10.15585/mmwr.mm7241e1

Vancouver

Fleming-Dutra KE, Jones JM, Roper LE, Prill MM, Ortega-Sanchez IR, Moulia DL, et al. Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023. MMWR. Morbidity and Mortality Weekly Report. 2023;72(41):1115-1122. doi:10.15585/mmwr.mm7241e1

BibTeX
@article{FlemingDutra2023,
  author = {Fleming-Dutra, Katherine E and Jones, Jefferson M and Roper, Lauren E and Prill, Mila M and Ortega-Sanchez, Ismael R and Moulia, Danielle L and Wallace, Megan and Godfrey, Monica and Broder, Karen R and Tepper, Naomi K and Brooks, Oliver and Sánchez, Pablo J and Kotton, Camille N and Mahon, Barbara E and Long, Sarah S and McMorrow, Meredith L},
  title = {Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023},
  journal = {MMWR. Morbidity and Mortality Weekly Report},
  year = {2023},
  volume = {72},
  number = {41},
  pages = {1115--1122},
  doi = {10.15585/mmwr.mm7241e1}
}
Kostenlos starten →